Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 496 AL 510

Alzheimer's drugs, APPlication for Down syndrome?

Sokol DK, Lahiri DK.

Ageing Res Rev. 2024 Apr;96:102281. doi: 10.1016/j.arr.2024.102281. Epub 2024 Mar 19.

Profiling lecanemab as a treatment option for Alzheimer's disease

Schiller ER, Silverglate BD, Grossberg GT.

Expert Rev Neurother. 2024 May;24(5):433-441. doi: 10.1080/14737175.2024.2333970. Epub 2024 Apr 3.

Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1

Fessel J.

Int J Mol Sci. 2024 Mar 31;25(7):3909. doi: 10.3390/ijms25073909.

[Role of NLRP3 inflammasome in prevention and treatment of cognitive impairment-related diseases and traditional Chinese medicine intervention: a review]

Wang CH, Wei XT, Zhao YQ, Wang DH, Xue JJ, Song ZQ, Tang F, Liu RX, Wang CA.

Zhongguo Zhong Yao Za Zhi. 2024 Feb;49(4):902-911. doi: 10.19540/j.cnki.cjcmm.20230913.403.

Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study

Wisch JK, McKay NS, Boerwinkle AH, Kennedy J, Flores S, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, O'Bryant SE, Price JC, Laymon CM, Krinsky-McHale SJ, Lai F, Rosas HD, Hartley SL, Zaman S, Lott IT, Tudorascu D, Zammit M, Brickman AM, Lee JH, Bird TD, Cohen A, Chrem P, Daniels A, Chhatwal JP, Cruchaga C, Ibanez L, Jucker M, Karch CM, Day GS, Lee JH, Levin J, Llibre-Guerra J, Li Y, Lopera F, Roh JH, Ringman JM, Supnet-Bell C, van Dyck CH, Xiong C, Wang G, Morris JC, McDade E, Bateman RJ, Benzinger TLS, Gordon BA, Ances BM; Alzheimer's Biomarker Consortium-Down syndrome; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.

Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies

Cai J, Xie D, Kong F, Zhai Z, Zhu Z, Zhao Y, Xu Y, Sun T.

J Alzheimers Dis. 2024;99(1):53-84. doi: 10.3233/JAD-231249.

The advent of Alzheimer treatments will change the trajectory of human aging

Selkoe DJ.

Nat Aging. 2024 Apr;4(4):453-463. doi: 10.1038/s43587-024-00611-5. Epub 2024 Apr 19.

Risk of Dementia and Alzheimer's Disease Associated With Antidiabetics: A Bayesian Network Meta-Analysis

Sunwoo Y, Park J, Choi CY, Shin S, Choi YJ.

Am J Prev Med. 2024 Sep;67(3):434-443. doi: 10.1016/j.amepre.2024.04.014. Epub 2024 May 4.

A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer's Disease

Parums DV.

Med Sci Monit. 2024 May 13;30:e945091. doi: 10.12659/MSM.945091.

Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer's

Song T, Wang Y, Silverglate BD, Grossberg GT.

Expert Opin Drug Metab Toxicol. 2024 Jun;20(6):411-417. doi: 10.1080/17425255.2024.2357637. Epub 2024 May 20.

Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials

Marinheiro G, Dantas JM, Mutarelli A, Menegaz de Almeida A, Monteiro GA, Zerlotto DS, Telles JPM.

Neurol Sci. 2024 Oct;45(10):4679-4686. doi: 10.1007/s10072-024-07576-8. Epub 2024 May 20.

Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline

Azargoonjahromi A.

J Pharm Pharmacol. 2024 Sep 3;76(9):1115-1131. doi: 10.1093/jpp/rgae066.

Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease

Li J, Haj Ebrahimi A, Ali AB.

Int J Mol Sci. 2024 May 9;25(10):5169. doi: 10.3390/ijms25105169.

Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease

Wang HJ, Chinna-Meyyappan A, Feldman OJ, Lanctôt KL.

Expert Opin Emerg Drugs. 2024 Sep;29(3):289-303. doi: 10.1080/14728214.2024.2363215. Epub 2024 Jun 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias